Serveur d'exploration sur les pandémies grippales

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Preventing and treating secondary bacterial infections with antiviral agents.

Identifieur interne : 001053 ( PubMed/Corpus ); précédent : 001052; suivant : 001054

Preventing and treating secondary bacterial infections with antiviral agents.

Auteurs : Jonathan A. Mccullers

Source :

RBID : pubmed:21447860

English descriptors

Abstract

Bacterial super-infections contribute to the significant morbidity and mortality associated with influenza and other respiratory virus infections. There are robust animal model data, but only limited clinical information on the effectiveness of licensed antiviral agents for the treatment of bacterial complications of influenza. The association of secondary bacterial pathogens with fatal pneumonia during the recent H1N1 influenza pandemic highlights the need for new development in this area. Basic and clinical research into viral-bacterial interactions over the past decade has revealed several mechanisms that underlie this synergism. By applying these insights to antiviral drug development, the potential exists to improve outcomes by means other than direct inhibition of the virus.

DOI: 10.3851/IMP1730
PubMed: 21447860

Links to Exploration step

pubmed:21447860

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Preventing and treating secondary bacterial infections with antiviral agents.</title>
<author>
<name sortKey="Mccullers, Jonathan A" sort="Mccullers, Jonathan A" uniqKey="Mccullers J" first="Jonathan A" last="Mccullers">Jonathan A. Mccullers</name>
<affiliation>
<nlm:affiliation>Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN, USA. jon.mccullers@stjude.org</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:21447860</idno>
<idno type="pmid">21447860</idno>
<idno type="doi">10.3851/IMP1730</idno>
<idno type="wicri:Area/PubMed/Corpus">001053</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001053</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Preventing and treating secondary bacterial infections with antiviral agents.</title>
<author>
<name sortKey="Mccullers, Jonathan A" sort="Mccullers, Jonathan A" uniqKey="Mccullers J" first="Jonathan A" last="Mccullers">Jonathan A. Mccullers</name>
<affiliation>
<nlm:affiliation>Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN, USA. jon.mccullers@stjude.org</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Antiviral therapy</title>
<idno type="eISSN">2040-2058</idno>
<imprint>
<date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Antiviral Agents (therapeutic use)</term>
<term>Bacterial Infections (complications)</term>
<term>Bacterial Infections (drug therapy)</term>
<term>Bacterial Infections (prevention & control)</term>
<term>Child, Preschool</term>
<term>Disease Models, Animal</term>
<term>Humans</term>
<term>Influenza A Virus, H1N1 Subtype</term>
<term>Influenza, Human (complications)</term>
<term>Influenza, Human (drug therapy)</term>
<term>Influenza, Human (virology)</term>
<term>Mice</term>
<term>Oseltamivir (therapeutic use)</term>
<term>Pneumonia, Bacterial (complications)</term>
<term>Pneumonia, Bacterial (drug therapy)</term>
<term>Pneumonia, Bacterial (prevention & control)</term>
<term>Randomized Controlled Trials as Topic</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antiviral Agents</term>
<term>Oseltamivir</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Bacterial Infections</term>
<term>Influenza, Human</term>
<term>Pneumonia, Bacterial</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Bacterial Infections</term>
<term>Influenza, Human</term>
<term>Pneumonia, Bacterial</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Bacterial Infections</term>
<term>Pneumonia, Bacterial</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Child, Preschool</term>
<term>Disease Models, Animal</term>
<term>Humans</term>
<term>Influenza A Virus, H1N1 Subtype</term>
<term>Mice</term>
<term>Randomized Controlled Trials as Topic</term>
<term>Treatment Outcome</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Bacterial super-infections contribute to the significant morbidity and mortality associated with influenza and other respiratory virus infections. There are robust animal model data, but only limited clinical information on the effectiveness of licensed antiviral agents for the treatment of bacterial complications of influenza. The association of secondary bacterial pathogens with fatal pneumonia during the recent H1N1 influenza pandemic highlights the need for new development in this area. Basic and clinical research into viral-bacterial interactions over the past decade has revealed several mechanisms that underlie this synergism. By applying these insights to antiviral drug development, the potential exists to improve outcomes by means other than direct inhibition of the virus.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">21447860</PMID>
<DateCompleted>
<Year>2011</Year>
<Month>07</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">2040-2058</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>16</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2011</Year>
</PubDate>
</JournalIssue>
<Title>Antiviral therapy</Title>
<ISOAbbreviation>Antivir. Ther. (Lond.)</ISOAbbreviation>
</Journal>
<ArticleTitle>Preventing and treating secondary bacterial infections with antiviral agents.</ArticleTitle>
<Pagination>
<MedlinePgn>123-35</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3851/IMP1730</ELocationID>
<Abstract>
<AbstractText>Bacterial super-infections contribute to the significant morbidity and mortality associated with influenza and other respiratory virus infections. There are robust animal model data, but only limited clinical information on the effectiveness of licensed antiviral agents for the treatment of bacterial complications of influenza. The association of secondary bacterial pathogens with fatal pneumonia during the recent H1N1 influenza pandemic highlights the need for new development in this area. Basic and clinical research into viral-bacterial interactions over the past decade has revealed several mechanisms that underlie this synergism. By applying these insights to antiviral drug development, the potential exists to improve outcomes by means other than direct inhibition of the virus.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>McCullers</LastName>
<ForeName>Jonathan A</ForeName>
<Initials>JA</Initials>
<AffiliationInfo>
<Affiliation>Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN, USA. jon.mccullers@stjude.org</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 AI066349</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R21 AI076816</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>AI-66349</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>AI-76816</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Antivir Ther</MedlineTA>
<NlmUniqueID>9815705</NlmUniqueID>
<ISSNLinking>1359-6535</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>20O93L6F9H</RegistryNumber>
<NameOfSubstance UI="D053139">Oseltamivir</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001424" MajorTopicYN="N">Bacterial Infections</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053118" MajorTopicYN="Y">Influenza A Virus, H1N1 Subtype</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053139" MajorTopicYN="N">Oseltamivir</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018410" MajorTopicYN="N">Pneumonia, Bacterial</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2011</Year>
<Month>3</Month>
<Day>31</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2011</Year>
<Month>3</Month>
<Day>31</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2011</Year>
<Month>7</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">21447860</ArticleId>
<ArticleId IdType="doi">10.3851/IMP1730</ArticleId>
<ArticleId IdType="pmc">PMC4907367</ArticleId>
<ArticleId IdType="mid">NIHMS790592</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1966-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12569171</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2004 Aug 1;190(3):519-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15243927</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Public Health. 2009 Oct;99 Suppl 2:S225-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19797736</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Signal. 2010 Feb;22(2):314-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19796680</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2003 Mar 15;187(6):1000-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12660947</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2004 Sep 1;39(5):681-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15356783</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2003 Dec 15;188(12):1928-39</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14673774</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Intern Med. 2006 Oct 17;145(8):599-609</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16940336</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Chin Med J (Engl). 2008 Sep 5;121(17):1607-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19024084</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2010 Feb 15;184(4):2048-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20083661</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Med Res. 2009 Nov;40(8):655-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20304252</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Expert Opin Pharmacother. 2008 Feb;9(2):151-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18201141</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2008 Apr 18;133(2):235-49</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18423196</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Bull Hist Med. 2002 Spring;76(1):105-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11875246</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatr Infect Dis J. 2010 Aug;29(8):731-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20351618</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatr Infect Dis J. 2010 Jun;29(6):519-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20051928</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Crit Care Med. 2010 Apr;38(4 Suppl):e74-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20035216</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antimicrob Agents Chemother. 2004 May;48(5):1495-502</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15105096</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Thorax. 2009 Mar;64(3):252-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19052043</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2006 Feb 1;193(3):387-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16388486</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Opin Infect Dis. 2006 Apr;19(2):169-78</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16514342</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2009 May 15;199(10):1497-505</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19392624</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Yale J Biol Med. 1968 Apr-Jun;40(5-6):522-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">4386279</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Infect Immun. 2006 May;74(5):2562-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16622191</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2010 Apr 16;328(5976):357-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20339031</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Virol. 2010 Apr;47(4):388-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20133186</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Infect Immun. 2006 Dec;74(12):6707-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16982840</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2009 Nov 4;302(17 ):1880-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19822626</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2002 Aug 1;186(3):341-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12134230</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Biosci. 2001 Aug 01;6:D877-89</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11502489</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2002 Mar 2;359(9308):753-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11888586</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2003 Feb 15;36(4):389-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12567294</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hong Kong Med J. 2006 Dec;12(6):489</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17148811</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2006 Nov 1;177(9):6182-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17056547</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2009 Jul 24;325(5939):481-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19574348</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Soc Trans. 2009 Aug;37(Pt 4):811-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19614599</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Microbiol Rev. 2006 Jul;19(3):571-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16847087</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2005 Jul 15;192(2):249-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15962219</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Future Microbiol. 2008 Aug;3(4):397-404</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18651811</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 1980 Dec;142(6):923-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7462701</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Ther. 2007 Oct;29(10):2246-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18042482</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2009 Jun 15;48(12 ):1639-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19435433</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Scand J Infect Dis. 2008;40(1):11-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17852951</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Clin Microbiol Infect Dis. 2005 Mar;24(3):190-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15782278</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Physiol Lung Cell Mol Physiol. 2006 Jan;290(1):L194-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16100290</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Evid Based Complement Alternat Med. 2010 Dec;7(4):501-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19779008</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Intern Med. 2003 Jul 28;163(14):1667-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12885681</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Crit Care Med. 2010 Apr;38(4 Suppl):e66-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20154602</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Exp Med. 2008 Feb 18;205(2):323-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18227219</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Chem. 2010 Apr 8;53(7):2998-3002</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20222714</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2008 Aug;14(8):1193-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18680641</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2006 May 1;193(9):1236-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16586360</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Pathol. 2010 Feb;176(2):800-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20042666</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Antimicrob Agents. 2010 May;35(5):421-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20185273</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 1959 Jan;38(1 Part 2):213-65</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">13620784</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Respir Crit Care Med. 2010 Jan 1;181(1):72-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19875682</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatrics. 2009 Jul;124(1):170-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19564297</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Microbiol. 2004 Jul;2(7):552-68</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15197391</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Influenza Other Respir Viruses. 2009 Jul;3(4):129-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19627370</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatr Infect Dis J. 2001 Feb;20(2):127-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11224828</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2004 Nov 1;190(9):1661-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15478073</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2009 Nov 4;302(17 ):1872-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19822627</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Crit Care Med. 2009 Feb;37(2):614-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19114898</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 1987 Feb 5-11;325(6104):536-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3543690</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MMWR Morb Mortal Wkly Rep. 2009 Oct 2;58(38):1071-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19798021</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2005 May;79(10):6035-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15857989</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Comp Med. 2007 Feb;57(1):82-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17348295</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMJ. 2003 Jun 7;326(7401):1235</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12791735</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MMWR Morb Mortal Wkly Rep. 2010 Apr 16;59(14):423-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20395936</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2007 Aug 1;45(3):315-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17599308</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2009 Aug 13;361(7):680-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19564631</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2008 May;14(5):558-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18438414</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Med Microbiol Immunol. 2010 Nov;199(4):291-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20386921</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2009 Nov 30;4(11):e8087</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19956645</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am Rev Respir Dis. 1986 Nov;134(5):1040-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3777666</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2009 Dec 24;139(7):1255-67</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20064372</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatr Infect Dis J. 2004 Jan;23(1 Suppl):S87-97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14730275</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 1998 Dec 20;252(2):324-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9878611</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2010 Feb;16(2):314-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20113569</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatrics. 2008 Oct;122(4):805-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18829805</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatr Infect Dis J. 2000 Apr;19(4):293-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10783017</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Microbiol. 2009 Sep;11(9):1399-408</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19500108</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Pediatr Adolesc Med. 2010 Jan;164(1):24-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20048238</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMJ. 2009 Dec 08;339:b5106</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19995812</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2003 May 1;21(16):1796-800</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12686097</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2002 Apr 15;34(8):1084-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11914997</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatr Infect Dis J. 2005 Sep;24(9):801-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16148847</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2009 Aug 21;27 Suppl 3:C9-C14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19683658</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5306-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19279209</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Jpn J Infect Dis. 2008 Nov;61(6):446-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19050351</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2010 Oct 15;202(8):1287-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20822454</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Pathol. 2010 Jul;177(1):166-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20508031</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2007 Aug;81(16):8593-600</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17553891</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Virol. 2008 Oct;80(10):1843-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18712820</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Antimicrob Chemother. 2003 Jan;51(1):123-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12493796</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2009 Aug 20;460(7258):1021-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19672242</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Respir Crit Care Med. 2004 Aug 15;170(4):440-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15184200</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatr Infect Dis J. 2009 Apr;28(4):337-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19258921</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2006 Jul 15;43(2):199-205</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16779747</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2007 Oct 4;357(14):1450-1</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17914053</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int Rev Immunol. 2009;28(1):69-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19241254</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Microbiol. 2008 Sep;46(9):3063-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18650351</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Epidemiol Infect. 2010 Sep;138(9):1281-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20109259</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Infect Immun. 1982 Apr;36(1):289-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7076299</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Respir Crit Care Med. 2010 Jul 1;182(1):41-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20203241</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2010 Mar;84(6):3127-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20042511</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2010 Feb 1;50(3):391-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20047483</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2010 Apr 1;50(7):963-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20180701</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2009 Feb 1;199(3):311-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19113989</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Public Health. 2010 Mar 29;10:168</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20346187</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Respirology. 2009 Nov;14(8):1173-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19909463</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2006 Nov 16;444(7117):378-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17108965</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Roum Arch Microbiol Immunol. 2009 Apr-Jun;68(2):80-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20361525</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Exp Immunol. 1998 Mar;111(3):583-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9528903</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 2008 Oct;89(Pt 10):2359-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18796704</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2010 Feb 15;201(4):508-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20078212</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatrics. 2004 Apr;113(4):701-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15060215</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2007 Apr 1;195(7):1038-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17330795</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Infect Dis. 2010 Jan 07;10:5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20059763</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2006 Apr 20;354(16):1671-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16625008</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2008 Oct 1;198(7):962-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18710327</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Pathog. 2010 Jul 08;6(7):e1000990</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20628565</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2011 Mar 15;203(6):880-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21278211</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Expert Opin Investig Drugs. 2005 Mar;14(3):305-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15833061</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2009 Jan 1;48 Suppl 1:S3-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19067613</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2004 Feb 15;189(4):711-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14767826</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Host Microbe. 2007 Oct 11;2(4):240-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18005742</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Microbiol Rev. 2002 Jan;15(1):95-110</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11781269</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Physiol Lung Cell Mol Physiol. 2005 Oct;289(4):L606-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15951332</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Immunol. 2008 Sep;9(9):1074-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18660812</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Pathog. 2007 Mar;3(3):e28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17381239</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2006 Apr 21;312(5772):399</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16556800</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Pharm Sci. 2009 Oct 8;38(3):215-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19616097</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2010 Jan;84(1):558-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19828614</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1996 Dec;70(12):8624-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8970987</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Paediatr Respir Rev. 2004;5 Suppl A:S191-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14980269</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Pathol Lab Med. 2010 Feb;134(2):235-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20121613</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>AMA Arch Intern Med. 1959 Apr;103(4):532-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">13636471</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2010 Apr 1;201(7):1007-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20170378</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2003 Jan 8;289(2):179-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12517228</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2008 Jun 10;105(23):8091-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18523003</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2007 Feb 15;195(4):581-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17230418</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antimicrob Agents Chemother. 2005 Jan;49(1):398-405</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15616320</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2009 Apr 15;48(8):1003-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19281331</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2010 Feb 1;201(3):354-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20039806</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Pharmacol. 2010 Feb 1;79(3):413-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19732754</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2007 Nov 1;196(9):1321-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17922396</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antimicrob Agents Chemother. 2007 Aug;51(8):2965-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17562808</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2004 Aug;10(8):811-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15247911</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2006 Mar 15;193(6):751-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16479505</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Natl Vital Stat Rep. 2007 Aug 21;55(19):1-119</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17867520</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2010 Apr;84(8):4105-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20130054</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2010 Jun 1;201(11):1611-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20415534</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2006 Feb;80(4):1629-36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16439519</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2008 Aug 15;198(4):561-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18598194</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Pathog. 2010 Jul 22;6(7):e1001014</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20661425</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Recent Pat Antiinfect Drug Discov. 2010 Jun;5(2):152-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20334616</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001053 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001053 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:21447860
   |texte=   Preventing and treating secondary bacterial infections with antiviral agents.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:21447860" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a PandemieGrippaleV1 

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021